Global Phototherapy Treatment Market Strategic Research Report

Scope of the Report

The global Phototherapy Treatment market size is predicted to grow from US$ 474 million in 2025 to US$ 676 million in 2032; it is expected to grow at a CAGR of 5.3% from 2026 to 2032.

Phototherapy treatment is a medical therapy that uses light to treat various health conditions, particularly skin disorders and certain types of jaundice. The therapy involves exposing the skin to ultraviolet (UV) light or visible light under controlled conditions, which can help in the treatment of conditions like psoriasis, eczema, vitiligo, and neonatal jaundice. Phototherapy can be administered through special lightboxes, lamps, or handheld devices. By penetrating the skin, the light helps to regulate the immune system, reduce inflammation, and promote the healing of skin cells. In the case of jaundice in newborns, phototherapy is used to break down excess bilirubin in the bloodstream, aiding in its removal and improving the infant’s condition.

The phototherapy treatment market is primarily driven by the increasing prevalence of skin disorders, such as psoriasis, eczema, and vitiligo, as well as the rising rates of neonatal jaundice, which necessitate effective treatments. The growing awareness of the benefits of light-based therapies and their non-invasive nature has also contributed to the market's expansion. Phototherapy is considered a safe and effective alternative to more aggressive treatments, such as systemic medications, and is gaining traction in both developed and emerging markets. Additionally, advancements in phototherapy devices, such as home-use phototherapy systems and portable light therapy units, are making treatment more accessible and convenient for patients, further fueling market growth.

However, the phototherapy treatment market faces several challenges, including the potential side effects of long-term UV exposure, such as skin aging and an increased risk of skin cancer. There are also concerns related to the cost of high-quality phototherapy devices, which can be prohibitively expensive for some patients, especially in low-income regions. Moreover, while phototherapy is effective for certain conditions, it may not be suitable for all patients, and the need for consistent treatment regimens can be a barrier for patient adherence. The market also faces regulatory hurdles in terms of device safety and efficacy, requiring manufacturers to comply with stringent medical standards and obtain necessary approvals.

Global key players of Phototherapy Treatment include GE Healthcare, Atom Medical, Draeger, Herbert Waldmann, Natus Medical, Daavlin, Beurer and National Biological, etc. Top three players occupy for a share about 19%. North America is the largest market, with a share about 31%, followed by Europe and Asia-Pacific. In terms of product, LED Phototherapy Treatment is the largest segment, with a share over 59%. In terms of application, Hospital and Clinic is the largest market, with a share over 84%.

This report presents a comprehensive overview of the global Phototherapy Treatment market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Conventional
• LED
• Fiberoptic

Segment by players, this report covers

• GE Healthcare
• Atom Medical
• Draeger
• Herbert Waldmann
• Natus Medical
• Daavlin
• Beurer
• National Biological
• DAVID
• Solarc Systems
• UVBioTek
• MTTS Asia
• Nice Neotech

Segment by Application

• Hospital & Clinic
• Home

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Phototherapy Treatment market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospital & Clinic, Home evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact